---
blocking_issues_count: 0
warnings_count: 8
tasklist_ready: true
---

## Findings

### Schema (Dimension 1)

- **[INFO]** Schema: Roadmap frontmatter lacks explicit `total_requirements` or `phases` count fields present in extraction frontmatter.
  - Location: roadmap.md:1-9
  - Evidence: Extraction frontmatter includes `functional_requirements: 31`, `nonfunctional_requirements: 10`, etc. Roadmap frontmatter omits these, relying on the Scope Summary table in §1 instead.
  - Fix guidance: No action required. The Scope Summary table at roadmap.md:§1 contains all counts inline.

### Structure (Dimension 2)

No issues found. Heading hierarchy is H1 > H2 > H3 > H4 with no gaps. Milestone DAG is acyclic (Pre-impl → Phase 1 → {Phase 2, Phase 3} → Phase 4). No duplicate deliverable IDs within phases. All internal references (FR-xxx, SC-xxx, RSK-xxx, OQ-xxx) resolve to defined items.

### Traceability (Dimension 3)

- **[WARNING]** Traceability: Extraction OQ-005 ("MEDIUM Severity Blocking Policy") is not explicitly resolved in the roadmap.
  - Location: extraction.md:§Open Questions:OQ-005 vs roadmap.md:§2 (OQ-005)
  - Evidence: Extraction defines OQ-005 as "Should MEDIUM severity become blocking for certain deviation categories?" The roadmap's OQ-005 resolution instead addresses timeout semantics (which corresponds to extraction's OQ-008). The MEDIUM blocking question is never explicitly resolved — the roadmap implicitly answers "no" by only implementing HIGH-severity blocking (FR-006, FR-015).
  - Fix guidance: Add an explicit resolution for the MEDIUM blocking policy question in roadmap §2, even if the answer is "Not for v2.20 — only HIGH blocks. Revisit in v2.21." This makes the implicit decision auditable.

### Cross-File Consistency (Dimension 4)

- **[WARNING]** Cross-file consistency: `test_fidelity_deviation_dataclass` has conflicting phase assignment between roadmap and test-strategy.
  - Location: roadmap.md:§3.1 Phase 1 Tests vs test-strategy.md:§2.1 "Phase 2 — Spec-Fidelity (6 tests)"
  - Evidence: Roadmap lists `test_fidelity_deviation_dataclass` under Phase 1 tests and SC-013 validation. Test-strategy §2.1 lists it under "Phase 2 — Spec-Fidelity" unit tests. However, test-strategy Milestone 1 table also maps SC-013 → `test_fidelity_deviation_dataclass`, which contradicts its own §2.1 placement.
  - Fix guidance: Move `test_fidelity_deviation_dataclass` to Phase 1 in test-strategy §2.1 (aligning with both the roadmap and test-strategy's own Milestone 1 table). Adjust Phase 1 count to 10 and Phase 2 count to 5.

- **[WARNING]** Cross-file consistency: Two unit tests exist only in test-strategy, not in roadmap.
  - Location: test-strategy.md:§2.1 Phase 2 vs roadmap.md:§3.2 Phase 2 Tests
  - Evidence: `test_fidelity_deviation_invalid_severity` and `test_build_spec_fidelity_prompt_structured_output` appear in test-strategy §2.1 but are absent from roadmap Phase 2 test listings. This means the roadmap understates the Phase 2 test scope.
  - Fix guidance: Add both tests to roadmap §3.2 Phase 2 "Tests" section under Unit tests, or explicitly note that the test-strategy is authoritative for individual test enumeration while the roadmap lists representative tests.

- **[INFO]** Cross-file consistency: Test-strategy `interleave_ratio` field uses "1:2" string format rather than a decimal.
  - Location: test-strategy.md:2 (frontmatter `interleave_ratio: '1:2'`)
  - Evidence: The value represents "one test cycle per two implementation deliverables" (§3), not the interleave_ratio formula from the validation spec. This is a different metric entirely — the test-strategy's ratio describes test-to-implementation cadence, not the phase coverage ratio computed in Dimension 6.
  - Fix guidance: No action needed, but be aware these are different metrics if automated tooling parses this field.

### Parseability (Dimension 5)

No issues found. All phases use numbered deliverables with FR references, bullet sub-items, checkbox exit criteria, and structured tables. Compatible with sc:tasklist heading/bullet/numbered-list splitter.

### Interleave (Dimension 6)

- **[WARNING]** Interleave: Pre-implementation phase has no code deliverables, only decision tasks.
  - Location: roadmap.md:§2 "Pre-Implementation Decisions (Days 1–3)"
  - Evidence: Pre-impl phase contains 8 decision resolutions and exit criteria but no testable code deliverables. This reduces the ratio.
  - Fix guidance: Acceptable by design (decisions must precede code). No action required, flagged for awareness.

### Decomposition (Dimension 7)

- **[WARNING]** Decomposition: Phase 1 deliverable 3 is compound — bundles format documentation, severity classification, and dataclass creation.
  - Location: roadmap.md:§3.1 Phase 1 Deliverables, item 3
  - Evidence: "Deviation report format definition (FR-021, FR-022, FR-023, FR-026)" covers: (a) `docs/reference/deviation-report-format.md` creation, (b) severity classification with examples, (c) `FidelityDeviation` dataclass (FR-031). These are 3 distinct outputs.
  - Fix guidance: sc:tasklist should split into: (1) Create deviation-report-format.md with 7-column schema, (2) Define severity classification examples, (3) Implement `FidelityDeviation` dataclass in `roadmap/fidelity.py`.

- **[WARNING]** Decomposition: Phase 4 deliverable 3 "Integration hardening" bundles 4 distinct verification activities.
  - Location: roadmap.md:§3.4 Phase 4 Deliverables, item 3
  - Evidence: Contains: (a) full pipeline run against 3+ specs, (b) cross-reference warning mode verification, (c) pipeline time delta measurement (SC-012), (d) --no-validate behavior verification (SC-014).
  - Fix guidance: sc:tasklist should split into individual verification tasks, each with its own success criterion.

- **[WARNING]** Decomposition: Phase 4 deliverable 4 "Rollout validation" bundles 5 distinct activities.
  - Location: roadmap.md:§3.4 Phase 4 Deliverables, item 4
  - Evidence: Contains: (a) historical artifact replay, (b) failure-state semantics documentation, (c) monitoring metrics definition, (d) rollback trigger threshold definition, (e) rollback plan preparation.
  - Fix guidance: sc:tasklist should split into separate tasks for artifact replay, metric definition, and rollback plan creation.

- **[WARNING]** Decomposition: Phase 4 deliverable 5 "Documentation updates" bundles 4 document updates.
  - Location: roadmap.md:§3.4 Phase 4 Deliverables, item 5
  - Evidence: Contains: (a) PLANNING.md update, (b) CLI help text update, (c) deviation format doc finalization, (d) operational guidance creation.
  - Fix guidance: sc:tasklist should split into individual documentation tasks.

## Summary

| Severity | Count |
|----------|-------|
| BLOCKING | 0 |
| WARNING | 8 |
| INFO | 2 |

**Overall Assessment**: The roadmap is **ready for tasklist generation**. No blocking issues were found. The 8 warnings are non-critical:
- 1 traceability gap (OQ-005 MEDIUM blocking policy implicitly resolved but not documented)
- 2 cross-file test enumeration inconsistencies (phase assignment mismatch, missing tests in roadmap)
- 1 interleave note (pre-impl phase has no code deliverables, by design)
- 4 compound deliverables in Phase 1 and Phase 4 that sc:tasklist will need to decompose

The roadmap demonstrates strong internal consistency, complete FR/NFR traceability, well-structured milestone DAG, and thorough test-to-deliverable mapping. Phase 4 carries the highest decomposition burden — sc:tasklist should anticipate splitting 3 of its 5 deliverables.

## Interleave Ratio

**Formula**: `interleave_ratio = unique_phases_with_deliverables / total_phases`

| Phase | Has Deliverables? |
|-------|-------------------|
| Pre-Implementation Decisions (Days 1–3) | No (decisions only) |
| Phase 1: Foundation (Days 4–8) | Yes |
| Phase 2: Spec-Fidelity Gate (Days 9–15) | Yes |
| Phase 3: Tasklist CLI (Days 16–22) | Yes |
| Phase 4: Retrospective & Hardening (Days 23–28) | Yes |

- unique_phases_with_deliverables = **4**
- total_phases = **5**
- **interleave_ratio = 4 / 5 = 0.80**

Value 0.80 is within acceptable range [0.1, 1.0]. ✓

Test activity distribution is well-interleaved: Phase 1 (9 unit), Phase 2 (6 unit + 5 integration), Phase 3 (5 unit + 2 integration + 1 E2E), Phase 4 (4 unit + 2 integration + 2 E2E). No back-loading detected.
